Lv517
1514 积分 2025-04-28 加入
Advances with the discovery and development of novel sigma 1 receptor antagonists for the management of pain
26天前
已完结
The role of beta-catenin in cell adhesion, signal transduction, and cancer
28天前
已完结
Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor
28天前
已完结
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors – a review of patent literature from 2019–June 2023
1个月前
已完结
PRT3789 is a First-in-Human SMARCA2-Selective Degrader that Induces Synthetic Lethality in SMARCA4-Mutated Cancers
1个月前
已完结
Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications
1个月前
已完结
Discovery of NKT3964: a first-in-class, highly potent and selective, orally bioavailable CDK2 PROTAC degrader for cancer therapy
2个月前
已关闭
Discovery of NKT3964: a first-in-class, highly potent and selective, orally bioavailable CDK2 PROTAC degrader for cancer therapy
2个月前
已关闭
14 (PB002): Discovery of NKT3964: a first-in-class, highly potent and selective, orally bioavailable CDK2 PROTAC degrader for cancer therapy
2个月前
已完结
Exploring the value of FAP-targeted PET/CT in differentiating breast cancer molecular subtypes: a preliminary study
3个月前
已完结
皖公网安备34019202002308
